Maneesh Pharmaceuticals Limited — Rifampicin Exporter Profile
Indian Pharmaceutical Exporter · #4 for Rifampicin · $11.2M export value · DGFT Verified
Maneesh Pharmaceuticals Limited is the #4 Indian exporter of Rifampicin with $11.2M in export value and 207 verified shipments. Maneesh Pharmaceuticals Limited holds a 0.8% market share in Rifampicin exports across 41 countries. The company exports 6 pharmaceutical products worth $31.9M across 4 therapeutic categories.
Maneesh Pharmaceuticals Limited — Rifampicin Export Profile: Buyers & Destinations
Where Does Maneesh Pharmaceuticals Limited Export Rifampicin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SUDAN | $643.1K | 13 | 10.7% |
| PHILIPPINES | $462.4K | 19 | 7.7% |
| KENYA | $449.8K | 17 | 7.5% |
| INDONESIA | $405.4K | 17 | 6.8% |
| AFGHANISTAN | $400.0K | 8 | 6.7% |
| CONGO | $353.7K | 12 | 5.9% |
| NAMBIA | $309.0K | 8 | 5.2% |
| ANGOLA | $263.5K | 8 | 4.4% |
| NETHERLANDS | $233.1K | 20 | 3.9% |
| BURUNDI | $200.0K | 6 | 3.3% |
Maneesh Pharmaceuticals Limited exports Rifampicin to 44 countries. The largest destination is SUDAN accounting for 10.7% of Maneesh Pharmaceuticals Limited's Rifampicin shipments, followed by PHILIPPINES (7.7%) and KENYA (7.5%). These destinations reflect Maneesh Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Rifampicin from Maneesh Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AMBICA INTERNATIONAL CORPORATION | PHILIPPINES | $462.4K | 19 |
| SEKRETARIAT DITJEN PENCEGAHAN DAN P | INDONESIA | $400.0K | 8 |
| UNOCA COMPOUND JALALABAD ROAD KABUL | AFGHANISTAN | $250.0K | 5 |
| COUNTRY OFFICE CO BURUNDI | BURUNDI | $200.0K | 4 |
| FEDERAL MINISTRY OF HEALTH | SUDAN | $200.0K | 4 |
| REPUBLIQUE DU CONGO PROGRAMME DES NATIONS UNIESPOUR LE | CONGO | $200.0K | 4 |
| FEDERAL MINISTRY OF HEALTH DIRECTORATE OF INTERNATIONAL HEALTHGRANTS | SUDAN | $200.0K | 4 |
| COSPHARM INV T/A M PLUS PHARMACEUTI | NAMBIA | $196.5K | 4 |
| UNDP SOUTH SUDAN | SUDAN | $193.1K | 4 |
| 5 KAMPALA | KENYA | $179.9K | 4 |
Maneesh Pharmaceuticals Limited supplies Rifampicin to 74 buyers globally. The largest buyer is AMBICA INTERNATIONAL CORPORATION (PHILIPPINES), followed by SEKRETARIAT DITJEN PENCEGAHAN DAN P (INDONESIA) and UNOCA COMPOUND JALALABAD ROAD KABUL (AFGHANISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Rifampicin Export Value and How Much Does Maneesh Pharmaceuticals Limited Contribute?
India exported $121.8M worth of Rifampicin through 3,913 shipments from 175 suppliers to 162 countries, serving 780 buyers globally. Maneesh Pharmaceuticals Limited contributes $11.2M to this total, accounting for 0.8% of India's Rifampicin exports. Maneesh Pharmaceuticals Limited ships Rifampicin to 44 countries through 74 buyers.
What Is the Average Shipment Value for Maneesh Pharmaceuticals Limited's Rifampicin Exports?
Maneesh Pharmaceuticals Limited's average Rifampicin shipment value is $54.1K per consignment, based on 207 shipments totaling $11.2M. The largest destination is SUDAN (10.7% of Maneesh Pharmaceuticals Limited's Rifampicin exports).
How Does Maneesh Pharmaceuticals Limited Compare to Other Indian Rifampicin Exporters?
Maneesh Pharmaceuticals Limited ranks #4 among 175 Indian Rifampicin exporters with a 0.8% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($64.0M), MACLEODS PHARMACEUTICALS LIMITED ($18.5M), LUPIN LIMITED ($18.4M). Maneesh Pharmaceuticals Limited processed 207 shipments to 41 destination countries.
What Rifampicin Formulations Does Maneesh Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| RIFAMPICIN 150MG / ISONIAZID 75MG / PYRA | $672.9K | 29 |
| RIFAMPICIN 150MG / ISONIAZID 75MG TABS E | $341.6K | 18 |
| RIFAMPICIN 150MG / ISONIAZID 75MG TABS EACH CARTON OF 24X28 TABS | $293.3K | 8 |
| RIFAMPICIN 150MG / ISONIAZID 75MG TABS EACH CARTON OF 24X28 TABS 5280 CARTONS | $150.0K | 3 |
| RIFAMPICIN 150MG / ISONIAZID 75MG / PYRAZINAMIDE 400MG /ETHAMBUTOL 275MG TABS EACH CARTON OF 24X28 TABS 2690 CARTONS | $150.0K | 3 |
| 6 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150 MG/ISONIAZID 75 MG/PYRAZINAMIDE 400MG/ETHAMBUTOL HCL 275MG TABLETS(25602 CNOS | $150.0K | 3 |
| 12 STRIPS OF 28 TABLETS EACH OF RIFAMPICIN 150 MG/ ISONIAZID 75 MG TABLETS (25602 CARTONS)NOS | $150.0K | 3 |
| RIFAMPICIN 150MG / ISONIAZID 75MG TABS EACH CARTON OF 24x28 TABS | $145.6K | 3 |
| PHARMA : RIFAMPICIN 150MG + ISONIAZID 75 | $143.1K | 3 |
| RIFAMPICIN 150MG/ISONIAZID 75MG/PYRAZINA | $106.3K | 3 |
Maneesh Pharmaceuticals Limited exports 121 distinct Rifampicin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is RIFAMPICIN 150MG / ISONIAZID 75MG / PYRA with 29 shipments worth $672.9K.
How Does Maneesh Pharmaceuticals Limited Compare to Nearest Rifampicin Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | MACLEODS PHARMACEUTICALS LIMITED | $18.5M | 387 | 87 | $47.7K |
| 1 | LUPIN LIMITED | $18.4M | 369 | 58 | $50.0K |
| 4 | MANEESH PHARMACEUTICALS LIMITED ★ | $10.3M | 207 | 41 | $50.0K |
| 5 | SVIZERA LABS PRIVATE LIMITED | $3.9M | 77 | 16 | $50.0K |
| 8 | SANDOZ PRIVATE LIMITED | $1.5M | 57 | 11 | $27.1K |
Maneesh Pharmaceuticals Limited ranks #4 among 175 Indian Rifampicin exporters. Average shipment value of $50.0K compared to the market average of $696.0K. The closest competitors by value are MACLEODS PHARMACEUTICALS LIMITED and LUPIN LIMITED.
Which Indian Ports Ship Rifampicin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 947 | 24.2% |
| SAHAR AIR | 813 | 20.8% |
| DELHI AIR CARGO ACC (INDEL4) | 477 | 12.2% |
| DELHI AIR | 404 | 10.3% |
| NHAVA SHEVA SEA (INNSA1) | 295 | 7.5% |
| Bombay Air | 175 | 4.5% |
| JNPT/ NHAVA SHEVA SEA | 116 | 3.0% |
| JNPT | 99 | 2.5% |
Geopolitical & Trade Policy Impact on Maneesh Pharmaceuticals Limited's Rifampicin Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Maneesh Pharmaceuticals. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)
Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceutical imports, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk. While Indian generics have largely remained exempt, any expansion of tariffs could adversely affect companies like Maneesh Pharmaceuticals, which rely on the US market for a significant portion of their exports. (pharma.economictimes.indiatimes.com)
The recent India-European Union Free Trade Agreement (FTA), signed on January 27, 2026, offers a favorable development. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing Maneesh Pharmaceuticals with enhanced access to European markets. This agreement is expected to boost India's pharmaceutical exports to the EU, presenting growth opportunities for the company. (en.wikipedia.org)
Maneesh Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements. Indian companies have faced increased scrutiny, leading to higher compliance costs and, in some cases, reduced export volumes. (transdatanexus.com)
For Maneesh Pharmaceuticals, maintaining adherence to these evolving standards is crucial to sustain and expand its export markets. Continuous investment in quality assurance and regulatory compliance will be essential to navigate the complex global regulatory environment and to meet the expectations of international partners and consumers.
About Maneesh Pharmaceuticals Limited
Maneesh Pharmaceuticals Limited exports 6 products worth $31.9M. Beyond Rifampicin, top products include Isoniazid, Ethambutol, Pyrazinamide, Strip, Primaquine. View the complete Maneesh Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rifampicin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Rifampicin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Maneesh Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 224 individual customs records matching Maneesh Pharmaceuticals Limited exporting Rifampicin, covering 121 formulations to 44 countries via 74 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 162+ countries, 780+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Rifampicin Export Data from Maneesh Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Maneesh Pharmaceuticals Limited's Rifampicin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Maneesh Pharmaceuticals Limited
Full Company Profile →
6 products · $31.9M total trade · 4 categories
Rifampicin Stats
Company Overview
Top Products by Maneesh Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Maneesh Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Rifampicin. For current shipment-level data, contact TransData Nexus.